BERLIN, Germany – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the publication of the IN-TIME study results in the medical journal The Lancet today. 1 The ...
BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...
(HealthDay News) – A software monitoring program that tracks implantable cardioverter-defibrillator lead function could detect problems with the devices earlier than current monitoring processes.
Patients with an implantable cardioverter-defibrillator (ICD) require follow-up to monitor their clinical status and device function. Remote home monitoring has the potential to reduce costs and ...
Everyday Health on MSN
Hypertrophic cardiomyopathy (HCM) and implantable devices: What to know about ICDs (and other options)
Two types of implantable cardioverter defibrillators can reduce the risk of sudden cardiac death with HCM. Pacemakers and implantable loop recorders also may be options.
A software monitoring program that tracks implantable cardioverter-defibrillator (ICD) function could detect problems with the devices earlier than current monitoring processes, according to new ...
Dr Melissa Walton-Shirley brings a personal and practice-focused perspective to headlines, research, and overlooked cardiology gems.
This week, Sorin Group announced that the FDA cleared SmartView, a remote monitoring application for patients with implanted cardiac rhythm management devices. The technology allows physicians whose ...
A group of cardiologists has called for closer monitoring of wire leads that connect to defibrillators and pacemakers in the heart in the wake of serious malfunctions and deaths that took place in ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results